SAMSUNG PHARM. Co., LTD.

Research SAMSUNG PHARM. Co., LTD. (001360.KS) on Bullrun: market cap KRW 122.17B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker001360.KS
ExchangeKS
CountrySouth Korea
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CurrencyKRW
Market capKRW 122.17B
Financial periodQ2 2026
RevenueKRW 9.90B
Net income-KRW 56.65B
Free cash flow-KRW 1.52B
Gross margin31.6%

Valuation Snapshot

latest market cap is KRW 122.17B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 122.17B	n/a	n/a	n/a

Dividend history

About SAMSUNG PHARM. Co., LTD.

SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, enzyme, mixed vitamins, antibiotics, and others.

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

Dongwha Pharm.Co.,Ltd (000020.KS) Yuhan Corporation (000100.KS) Yuyu Pharma, Inc. (000220.KS) Ildong Holdings Co., Ltd. (000230.KS) Samil Pharmaceutical Co.,Ltd (000520.KS) Dong-A Socio Holdings Co., Ltd. (000640.KS) JW Pharmaceutical Corporation (001060.KS) Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) Chong Kun Dang Holdings Corp. (001630.KS) Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) HANDOK Inc. (002390.KS) Jeil Pharma Holdings Inc (002620.KS)

Frequently asked questions

What is SAMSUNG PHARM. Co., LTD.'s market cap?

SAMSUNG PHARM. Co., LTD.'s market capitalization is KRW 122.17B.